Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

  1. Ribera, J.-M.
  2. Morgades, M.
  3. Garcia-Calduch, O.
  4. Sirvent, M.
  5. Buendia, B.
  6. Cervera, M.
  7. Luzardo, H.
  8. Hernandez-Rivas, J.-M.
  9. Sitges, M.
  10. Garcia-Cadenas, I.
  11. Abrisqueta, P.
  12. Montesinos, P.
  13. Bastos-Oreiro, M.
  14. De Llano, M.-P.Q.
  15. Bravo, P.
  16. Torrent, A.
  17. Herrera, P.
  18. Garcia-Guinon, A.
  19. Vall-Llovera, F.
  20. Serrano, J.
  21. Terol, M.-J.
  22. Bergua, J.-M.
  23. Garcia-Noblejas, A.
  24. Barrenetxea, C.
  25. Llorente, L.
  26. Garcia-Belmonte, D.
  27. Gimeno, E.
  28. Cladera, A.
  29. Mercadal, S.
  30. Sancho, J.-M.
  31. Show all authors +
Journal:
Haematologica

ISSN: 1592-8721

Year of publication: 2024

Volume: 109

Issue: 2

Pages: 543-552

Type: Article

DOI: 10.3324/HAEMATOL.2023.283342 GOOGLE SCHOLAR lock_openOpen access editor